Astrana Historical Financial Ratios

ASTH Stock

39.31 0.16 0.41%

Astrana Health is presently reporting on over 111 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0428, PTB Ratio of 4.22 or Days Sales Outstanding of 34.21 will help investors to properly organize and evaluate Astrana Health financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

About Astrana Financial Ratios Analysis

Astrana HealthFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Astrana Health investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Astrana financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Astrana Health history.

Astrana Health Financial Ratios Chart

As of now, Astrana Health's Free Cash Flow Yield is increasing as compared to previous years. The Astrana Health's current Capex To Depreciation is estimated to increase to 1.69, while Days Sales Outstanding is projected to decrease to 34.21.

Price To Sales Ratio Ptb Ratio Days Sales Outstanding Book Value Per Share Tangible Asset Value Debt To Equity

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Astrana Health stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Astrana Health sales, a figure that is much harder to manipulate than other Astrana Health multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Tangible Asset Value

The total value of a company's physical, tangible assets, excluding intangible assets like patents and trademarks.

Debt To Equity

A measure of a company's financial leverage calculated by dividing its total liabilities by stockholders' equity, indicating the proportion of equity and debt the company is using to finance its assets.

Most ratios from Astrana Health's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Astrana Health current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.As of now, Astrana Health's Free Cash Flow Yield is increasing as compared to previous years. The Astrana Health's current Capex To Depreciation is estimated to increase to 1.69, while Days Sales Outstanding is projected to decrease to 34.21.

	2021	2022	2023	2024 (projected)
Dividend Yield	0.009653	0.0105	0.0343	0.0428
Price To Sales Ratio	4.16	1.16	1.31	1.33

Dividend Yield Price To Sales Ratio

Astrana Health fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Net Income Per Share	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio
Price To Sales Ratio		-0.02	0.2	0.24	0.61	0.51	0.63	0.04	0.2	0.98	0.6	0.57	0.64	0.42	0.52	0.63	0.69	0.22	-0.12	0.5	0.68	-0.3	0.47	0.6	0.63	0.44
Dividend Yield	-0.02		-0.54	0.79	0.3	0.31	0.05	-0.32	-0.54	0.14	0.1	0.34	0.15	0.23	-0.26	0.49	0.48	-0.18	0.34	0.18	0.41	-0.41	-0.08	0.36	0.57	0.03
Ptb Ratio	0.2	-0.54		-0.28	-0.57	-0.65	-0.49	0.19	1.0	0.11	-0.5	-0.57	-0.37	-0.22	0.11	-0.57	-0.34	-0.21	0.02	-0.36	-0.25	0.25	-0.35	-0.56	-0.31	-0.08
Days Sales Outstanding	0.24	0.79	-0.28		0.23	0.12	-0.03	-0.13	-0.28	0.39	-0.05	0.24	0.1	0.38	-0.02	0.53	0.54	-0.52	0.24	0.2	0.47	-0.7	-0.14	0.27	0.63	0.12
Book Value Per Share	0.61	0.3	-0.57	0.23		0.97	0.92	-0.24	-0.57	0.63	0.94	0.97	0.87	0.45	0.24	0.85	0.83	0.56	0.07	0.63	0.73	-0.31	0.86	0.96	0.74	0.61
Free Cash Flow Yield	0.51	0.31	-0.65	0.12	0.97		0.94	-0.26	-0.65	0.53	0.97	0.95	0.83	0.36	0.18	0.81	0.73	0.65	-0.02	0.6	0.64	-0.18	0.81	0.94	0.64	0.48
Operating Cash Flow Per Share	0.63	0.05	-0.49	-0.03	0.92	0.94		-0.03	-0.49	0.62	0.98	0.89	0.89	0.42	0.43	0.81	0.69	0.62	-0.11	0.69	0.65	-0.17	0.82	0.9	0.59	0.5
Capex To Depreciation	0.04	-0.32	0.19	-0.13	-0.24	-0.26	-0.03		0.19	0.05	-0.18	-0.12	0.19	0.6	0.85	0.02	-0.03	-0.5	-0.07	0.56	0.23	-0.45	-0.17	-0.05	-0.03	0.02
Pb Ratio	0.2	-0.54	1.0	-0.28	-0.57	-0.65	-0.49	0.19		0.11	-0.5	-0.57	-0.37	-0.22	0.11	-0.57	-0.34	-0.21	0.02	-0.36	-0.25	0.25	-0.35	-0.56	-0.31	-0.08
Ev To Sales	0.98	0.14	0.11	0.39	0.63	0.53	0.62	0.05	0.11		0.58	0.61	0.66	0.49	0.53	0.72	0.76	0.12	-0.06	0.55	0.75	-0.42	0.43	0.65	0.73	0.44
Free Cash Flow Per Share	0.6	0.1	-0.5	-0.05	0.94	0.97	0.98	-0.18	-0.5	0.58		0.89	0.84	0.3	0.29	0.76	0.66	0.72	-0.12	0.59	0.59	-0.06	0.83	0.89	0.55	0.46
Roic	0.57	0.34	-0.57	0.24	0.97	0.95	0.89	-0.12	-0.57	0.61	0.89		0.93	0.6	0.32	0.83	0.88	0.5	0.18	0.74	0.82	-0.43	0.87	0.99	0.8	0.69
Net Income Per Share	0.64	0.15	-0.37	0.1	0.87	0.83	0.89	0.19	-0.37	0.66	0.84	0.93		0.72	0.6	0.8	0.86	0.43	0.23	0.88	0.89	-0.44	0.83	0.95	0.79	0.74
Payables Turnover	0.42	0.23	-0.22	0.38	0.45	0.36	0.42	0.6	-0.22	0.49	0.3	0.6	0.72		0.76	0.59	0.72	-0.26	0.29	0.92	0.86	-0.89	0.41	0.64	0.69	0.61
Capex To Revenue	0.52	-0.26	0.11	-0.02	0.24	0.18	0.43	0.85	0.11	0.53	0.29	0.32	0.6	0.76		0.44	0.4	-0.21	-0.07	0.81	0.6	-0.54	0.25	0.39	0.36	0.34
Cash Per Share	0.63	0.49	-0.57	0.53	0.85	0.81	0.81	0.02	-0.57	0.72	0.76	0.83	0.8	0.59	0.44		0.86	0.16	0.04	0.74	0.81	-0.54	0.53	0.88	0.83	0.42
Pocfratio	0.69	0.48	-0.34	0.54	0.83	0.73	0.69	-0.03	-0.34	0.76	0.66	0.88	0.86	0.72	0.4	0.86		0.18	0.42	0.74	0.96	-0.64	0.67	0.9	0.99	0.77
Interest Coverage	0.22	-0.18	-0.21	-0.52	0.56	0.65	0.62	-0.5	-0.21	0.12	0.72	0.5	0.43	-0.26	-0.21	0.16	0.18		-0.01	0.02	0.06	0.55	0.69	0.46	0.08	0.3
Payout Ratio	-0.12	0.34	0.02	0.24	0.07	-0.02	-0.11	-0.07	0.02	-0.06	-0.12	0.18	0.23	0.29	-0.07	0.04	0.42	-0.01		0.15	0.38	-0.27	0.23	0.18	0.5	0.67
Capex To Operating Cash Flow	0.5	0.18	-0.36	0.2	0.63	0.6	0.69	0.56	-0.36	0.55	0.59	0.74	0.88	0.92	0.81	0.74	0.74	0.02	0.15		0.87	-0.69	0.54	0.79	0.69	0.56
Pfcf Ratio	0.68	0.41	-0.25	0.47	0.73	0.64	0.65	0.23	-0.25	0.75	0.59	0.82	0.89	0.86	0.6	0.81	0.96	0.06	0.38	0.87		-0.72	0.59	0.86	0.94	0.73
Days Payables Outstanding	-0.3	-0.41	0.25	-0.7	-0.31	-0.18	-0.17	-0.45	0.25	-0.42	-0.06	-0.43	-0.44	-0.89	-0.54	-0.54	-0.64	0.55	-0.27	-0.69	-0.72		-0.17	-0.45	-0.66	-0.45
Income Quality	0.47	-0.08	-0.35	-0.14	0.86	0.81	0.82	-0.17	-0.35	0.43	0.83	0.87	0.83	0.41	0.25	0.53	0.67	0.69	0.23	0.54	0.59	-0.17		0.82	0.56	0.81
Roe	0.6	0.36	-0.56	0.27	0.96	0.94	0.9	-0.05	-0.56	0.65	0.89	0.99	0.95	0.64	0.39	0.88	0.9	0.46	0.18	0.79	0.86	-0.45	0.82		0.83	0.67
Ev To Operating Cash Flow	0.63	0.57	-0.31	0.63	0.74	0.64	0.59	-0.03	-0.31	0.73	0.55	0.8	0.79	0.69	0.36	0.83	0.99	0.08	0.5	0.69	0.94	-0.66	0.56	0.83		0.73
Pe Ratio	0.44	0.03	-0.08	0.12	0.61	0.48	0.5	0.02	-0.08	0.44	0.46	0.69	0.74	0.61	0.34	0.42	0.77	0.3	0.67	0.56	0.73	-0.45	0.81	0.67	0.73

Click cells to compare fundamentals

Astrana Health Account Relationship Matchups

Astrana Health fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	1.14	1.8	4.16	1.16	1.31	1.33
Dividend Yield	0.0966	0.0769	0.009653	0.0105	0.0343	0.0428
Ptb Ratio	3.34	2.02	7.19	2.45	2.95	4.22
Days Sales Outstanding	64.42	59.76	46.84	38.2	38.89	34.21
Book Value Per Share	10.4	12.19	11.65	12.42	8.79	8.26
Free Cash Flow Yield	0.0201	0.0674	0.0159	0.0445	0.0219	0.0223
Operating Cash Flow Per Share	0.4	1.26	1.6	1.83	1.46	0.9
Capex To Depreciation	0.057	0.0634	1.1	1.31	1.61	1.69
Pb Ratio	3.34	2.02	7.19	2.45	2.95	4.22
Ev To Sales	1.41	1.98	4.12	1.11	1.33	1.3
Free Cash Flow Per Share	0.37	1.23	1.17	1.32	0.85	0.73
Roic	0.0543	(3.77E-4)	0.092	0.0738	0.061	0.0641
Net Income Per Share	0.41	(0.65)	1.57	1.0	1.3	1.36
Payables Turnover	70.3	36.48	108.13	90.2	129.11	135.57
Capex To Revenue	0.001858	0.003144	0.0248	0.02	0.0206	0.0216
Cash Per Share	6.33	7.15	6.54	6.53	6.34	4.27
Pocfratio	45.93	14.46	45.79	16.2	26.55	16.86
Interest Coverage	7.27	2.41	18.2	13.16	5.25	4.99
Payout Ratio	4.37	(2.16)	0.45	0.31	1.02	0.95
Capex To Operating Cash Flow	0.0749	0.0252	0.27	0.28	0.42	0.44
Pfcf Ratio	49.64	14.83	63.01	22.48	45.63	47.91
Days Payables Outstanding	5.19	10.01	3.38	4.05	2.83	2.69
Income Quality	0.99	0.38	1.53	1.8	1.18	1.06
Roe	0.0737	(0.0718)	0.15	0.0833	0.0989	0.1
Ev To Operating Cash Flow	56.94	15.91	45.33	15.49	26.95	17.96
Pe Ratio	45.26	(28.1)	46.73	29.46	29.83	20.39
Return On Tangible Assets	0.0288	(0.0483)	0.13	0.0728	0.1	0.11
Ev To Free Cash Flow	61.55	16.32	62.38	21.49	46.31	48.63
Earnings Yield	0.0221	(0.0356)	0.0214	0.0339	0.0335	0.0352
Net Debt To E B I T D A	3.14	0.33	(0.32)	(0.52)	0.22	0.21
Current Ratio	3.12	2.94	3.53	2.88	2.11	2.02
Tangible Book Value Per Share	3.53	3.26	4.14	4.73	1.29	1.23
Receivables Turnover	5.67	6.11	7.79	9.56	9.39	10.51
Graham Number	7.11	11.51	19.02	16.51	19.61	9.88
Shareholders Equity Per Share	5.52	9.06	10.23	12.06	13.15	13.81
Debt To Equity	1.26	0.73	0.41	0.38	0.45	0.34
Capex Per Share	0.03	0.0319	0.44	0.51	0.61	0.64

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:

How To Invest In Astrana

Details

Is Astrana Stock a good investment?

Details

What is Astrana Health's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.30)

Earnings Share

1.3

Revenue Per Share

36.415

Quarterly Revenue Growth

0.375

Return On Assets

0.0449

The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Astrana Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Astrana Historical Financial Ratios

About Astrana Financial Ratios Analysis

Astrana Health Financial Ratios Chart

Price To Sales Ratio

Ptb Ratio

Book Value Per Share

Tangible Asset Value

Debt To Equity

Astrana Health fundamentals Correlations

Astrana Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Astrana Health fundamentals Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Roe	+ 0.99	Roic
Ev To Operating Cash Flow	+ 0.99	Pocfratio
Ev To Sales	+ 0.98	Price To Sales Ratio
Free Cash Flow Per Share	+ 0.98	Operating Cash Flow Per Share
Free Cash Flow Yield	+ 0.97	Book Value Per Share

Days Payables Outstanding	- 0.89	Payables Turnover
Days Payables Outstanding	- 0.72	Pfcf Ratio
Days Payables Outstanding	- 0.7	Days Sales Outstanding
Days Payables Outstanding	- 0.69	Capex To Operating Cash Flow
Ev To Operating Cash Flow	- 0.66	Days Payables Outstanding
Pb Ratio	- 0.65	Free Cash Flow Yield